Sex and racial differences in bladder cancer presentation and mortality in the US

Cancer

Volumn 115, Issue 1, 2009, Pages 68-74

  Scosyrev, Emil ^a   Noyes, Katia ^a   Feng, Changyong ^a   Messing, Edward ^a  

^a UNIVERSITY OF ROCHESTER   (United States)

Author keywords

Bladder cancer; Demographics; Mortality; Presentation

Indexed keywords

AFRICAN AMERICAN; AGED; ARTICLE; BLADDER CANCER; CANCER GRADING; CANCER MORTALITY; CANCER REGISTRY; CANCER STAGING; CONTROLLED STUDY; DATA BASE; FEMALE; FOLLOW UP; HUMAN; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; RACE DIFFERENCE; SEX DIFFERENCE; UNITED STATES; CANCER PROGNOSIS; CAUSE OF DEATH; CLINICAL FEATURE; HISTOPATHOLOGY; OUTCOME ASSESSMENT; RACISM;

AFRICAN AMERICANS; ETHNIC GROUPS; EUROPEAN CONTINENTAL ANCESTRY GROUP; FEMALE; HEALTH STATUS DISPARITIES; HUMANS; MALE; SEER PROGRAM; SEX FACTORS; URINARY BLADDER NEOPLASMS;

EID: 58949083565     PISSN: 0008543X     EISSN: 10970142     Source Type: Journal    
DOI: 10.1002/cncr.23986     Document Type: Article

References (28)

1. Jemal A, Siegel R, Ward E, Murray T, Xu J, Thun MJ. Cancer statistics, 2007. CA Cancer J Clin. 2007;57:43-66.
2. Botteman MF, Pashos CL, Redaelli A, Laskin B, Hauser R. The health economics of bladder cancer: a comprehensive review of the published literature. Pharmacoeconomics. 2003;21:1315-1330.
3. American Cancer Society. Estimated New Cancer Cases and Deaths by Sex for All Sites, US, 2007. Cancer Facts and Figures 2007. Available at: http://www.cancer.org/docroot/MED/content/ downloads/MED-1-1x-CFF2007-Estimated- New-Cases-Deaths-by-Sex-US.asp Accessed January 29, 2008.
4. Prout GR Jr, Wesley MN, McCarron PG, et al. Survival experience of black patients and white patients with bladder carcinoma. Cancer. 2004;100:621-630.
5. Mungan NA, Aben KK, Schoenberg MP, et al. Gender differences in stage-adjusted bladder cancer survival. Urology. 2000;55:876-880.
6. Cardenas-Turanzas M, Cooksley C, Pettaway CA, Sabichi A, Grossman HB, Elting L. Comparative outcomes of bladder cancer. Obstet Gynecol. 2006;108:169-175.
7. Underwood W 3rd, Dunn RL, Williams C, Lee CT. Gender and geographic influence on the racial disparity in bladder cancer mortality in the US. J Am Coll Surg. 2006;202:284-290.
8. Konety BR, Joslyn SA. Factors influencing aggressive therapy for bladder cancer: an analysis of data from the SEER Program. J Urol. 2003;170:1765-1771.
9. Prout GR Jr, Wesley MN, Greenberg RS, et al. Bladder cancer: race differences in extent of disease at diagnosis. Cancer. 2000;89:1349-1358.
10. Lee CT, Dunn RL, Williams C, Underwood W 3rd. Racial disparity in bladder cancer: trends in tumor presentation at diagnosis. J Urol. 2006;176:927-933.
11. Gloeckler Ries LA, Reichman ME, Lewis DR, Hankey BF, Edwards BK. Cancer survival and incidence from the Surveillance, Epidemiology, and End Results (SEER) Program. Oncologist. 2003;8:541-552.
12. Fleshner NE, Herr HW, Stewart AK, Murphy GP, Mettlin C, Menck HR. The National Cancer Data Base report on bladder carcinoma. The American College of Surgeons Commission on Cancer and the American Cancer Society. Cancer. 1996;78:1505-1513.
13. Walker G. Common Statistical Methods for Clinical Research. Cary, NC: SAS Institute Inc; 2002:67-73.
14. Marubini E, Valsecchi M. Analysing Survival Data from Clinical Trials and Observational Studies. New York, NY: John Wiley & Sons, Inc; 1995:346.
15. Prentice R, Kalbfleisch J, Peterson A, Flournoy N, Farewell V, Breslow N. The analysis of failure times in the presence of competing risks. Biometrics. 1978;34:541-554.
16. Collett D. Modelling Survival Data in Medical Research. 2nd ed. Boca Raton, Fla: CRC Press; 2003:141-148.
17. Marubini E, Valsecchi M. Analysing Survival Data from Clinical Trials and Observational Studies. New York, NY: John Wiley & Sons, Inc; 1995:235.
18. Patetta M. Survival Analysis Using the Proportional Hazards Model. Cary, NC: SAS Institute Inc; 2002:237-281.
19. Hosmer DW, Lemweshow S. Applied Survival Analysis: Regression Modeling of Time to Event Data. New York, NY: John Wiley & Sons, Inc; 1999:205-216.
20. Gore S, Pocock S, Kerr G. Regression models and nonproportional hazards in the analysis of breast cancer survival. Appl Stat. 1984;33:176-195.
21. McNeil D. Epidemiological Research Methods. New York, NY: John Wiley & Sons, Inc; 1996.
22. Szklo M, Nieto F. Epidemiology - Beyond the Basics. 2nd ed. Sudbury, Mass: Jones and Bartlet; 2007:167-168.
23. Messing EM, Madeb R, Young T, et al. Long-term outcome of hematuria home screening for bladder cancer in men. Cancer. 2006;107:2173-2179.
24. Snyder C, Harlan L, Knopf K, Potosky A, Kaplan R. Patterns of care for the treatment of bladder cancer. J Urol. 2003;169:1697-1701.
25. Taub DA, Hollenbeck BK, Cooper KL, et al. Racial disparities in resource utilization for cystectomy. Urology. 2006;67:288-293.
26. Schrag D, Hsieh L, Rabbani F, Bach P, Herr H, Begg C. Adherence to surveillance among patients with superficial bladder cancer. J Natl Cancer Inst. 2003;95:588-597.
27. Kochanek KD, Murphy SL, Anderson RN, Scott C. Deaths: final data for 2002. Natl Vital Stat Rep. 2004;53:1-115.
28. Kinsella K, Yvonne G. International Brief: Gender and Aging. Washington, DC: US Bureau of the Census; 1998. Available at: http://www.census.gov/ipc/prod/ ib98-2.pdf Accessed January 31, 2008.